Phytosphingosine Hydrochloride
122 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
122
Total Reports
0
Deaths Reported
0.0%
Death Rate
Active Ingredients
Phytosphingosine Hydrochloride
Administration Routes
TopicalAuricular (Otic)OphthalmicUnknown
Species Affected
Dog 95
Cat 19
Human 8
Most Affected Breeds
Crossbred Canine/dog 11
Domestic Shorthair 9
Mixed (Dog) 9
Unknown 8
Dog (unknown) 7
Shih Tzu 6
Retriever - Labrador 5
Shepherd Dog - German 4
Terrier - Yorkshire 4
Beagle 3
Most Reported Reactions
Application site erythema 18
Pruritus 11
Erythema (for urticaria see Immune SOC) 9
Application site pruritus 8
Emesis 5
Lethargy (see also Central nervous system depression in 'Neurological') 5
Ear discharge 5
Hives (see also 'Skin') 5
Vomiting 5
Ataxia 5
Application site dermatitis 5
Anorexia 4
Outcome Breakdown
Recovered/Normal
52 (42.6%)
Ongoing
44 (36.1%)
Outcome Unknown
18 (14.8%)
Recovered with Sequela
8 (6.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.